SCHEMBL1305535

SCHEMBL1305535

CCCCC/C=C/C(C=C(C)C)CCCCCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
CYP3A4 P08684 1/20 0.50
MAPT P10636 4/20 0.44
CYP2D6 P10635 3/20 0.44
MAPK1 P28482 3/20 0.44
TP53 P04637 2/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
SPHK2 Q9NRA0 4/20 0.44
SPHK1 Q9NYA1 4/20 0.44
CETP P11597 3/20 0.44
GMNN O75496 2/20 0.44
LMNA P02545 2/20 0.44
GLA P06280 2/20 0.44
POLB P06746 2/20 0.44
THRB P10828 2/20 0.44
CXCR5 P32302 2/20 0.44
CCR6 P51684 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1305538 1.00 MEN1 (0.50) MEN1KMT2ACYP3A4MAPTCYP2D6
SCHEMBL7768205 0.85 MEN1 (0.50) MEN1KMT2ACYP3A4MAPTCYP2D6
SCHEMBL6698177 0.85 MEN1 (0.50) MEN1KMT2ACYP3A4MAPTCYP2D6
SCHEMBL11806456 0.85 MEN1 (0.50) MEN1KMT2ACYP3A4MAPTCYP2D6
SCHEMBL28912345 0.78 MEN1 (0.44) MEN1KMT2ACYP3A4MAPTCYP2D6
SCHEMBL5067908 0.78 MEN1 (0.44) MEN1KMT2ACYP3A4MAPTCYP2D6
SCHEMBL27605243 0.78 PTGS1 (0.50) MEN1KMT2ACYP3A4MAPTCYP2D6
SCHEMBL10610904 0.78 FAAH (0.50) MEN1KMT2ACYP3A4MAPTCYP2D6
SCHEMBL3050134 0.78 FAAH (0.50) MEN1KMT2ACYP3A4MAPTCYP2D6
SCHEMBL7648924 0.76 MEN1 (0.47) MEN1KMT2ACYP3A4MAPTCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7012120-B2 Reworkable compositions of oxirane(s) or thirane(s)-containing resin and curing agent HENKEL CORPORATION (US) 2006-03-14 US claimed
US-20050288458-A1 Reworkable thermosetting resin composition KLEMARCZYK PHILIP T 2005-12-29 US claimed
US-20030073770-A1 Reworkable compositions of oxirane(s) or thirane(s)-containing resin and curing agent Henkel IP & Holding GmbH (DE) 2003-04-17 US claimed
US-8053587-B2 for mounting onto a circuit board semiconductor devices HENKEL CORPORATION (US) 2011-11-08 US disclosed
US-20080214840-A1 Reworkable thermosetting resin composition HENKEL CORPORATION (US) 2008-09-04 US disclosed
US-7012120-B2 Reworkable compositions of oxirane(s) or thirane(s)-containing resin and curing agent HENKEL CORPORATION (US) 2006-03-14 US disclosed
US-20050288458-A1 Reworkable thermosetting resin composition KLEMARCZYK PHILIP T 2005-12-29 US disclosed
US-20030073770-A1 Reworkable compositions of oxirane(s) or thirane(s)-containing resin and curing agent Henkel IP & Holding GmbH (DE) 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214840-A1 Reworkable thermosetting resin composition GSS, LSS, LRBA MEN1 4450/4885KMT2A 586/4885CYP3A4 2952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.